SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-050460
Filing Date
2020-11-04
Accepted
2020-11-04 16:05:58
Documents
14
Period of Report
2020-11-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mnkd-8k_20201104.htm   iXBRL 8-K 30375
2 EX-99.1 mnkd-ex991_6.htm EX-99.1 476554
3 GRAPHIC gwln2mlghjcm000001.jpg GRAPHIC 2721
  Complete submission text file 0001564590-20-050460.txt   659916

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mnkd-20201104.xsd EX-101.SCH 5792
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnkd-20201104_lab.xml EX-101.LAB 19478
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnkd-20201104_pre.xml EX-101.PRE 11642
7 EXTRACTED XBRL INSTANCE DOCUMENT mnkd-8k_20201104_htm.xml XML 3560
Mailing Address 30930 RUSSELL RANCH ROAD SUITE 300 WESTLAKE VILLAGE CA 91362
Business Address 30930 RUSSELL RANCH ROAD SUITE 300 WESTLAKE VILLAGE CA 91362 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

IRS No.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50865 | Film No.: 201286679
SIC: 2834 Pharmaceutical Preparations